Proton pump inhibitors interfere with the anti-tumor potency of RC48ADC-Reference-Cited by-同舟云学术

Proton pump inhibitors interfere with the anti-tumor potency of RC48ADC

Published:2022-03 Issue: Volume:79 Page:105292
ISSN:0887-2333
Container-title:Toxicology in Vitro
language:en
Short-container-title:Toxicology in Vitro

Author:

Zhang Xinling,Wang Yue,Luo Wenting,Zhu Marie M.,Huang Changjiang

Funder

Postdoctoral Research Foundation of China

China Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference30 articles.

1. Effect of icosapent ethyl (eicosapentaenoic acid ethyl ester) on omeprazole plasma pharmacokinetics in healthy adults;Braeckman;Drugs R D,2014

2. Lack of drug–drug interaction between cimetidine, a renal transporter inhibitor, and imeglimin, a novel oral antidiabetic drug, in healthy volunteers;Chevalier;Eur. J. Drug Metab. Pharmacokinet.,2020

3. Effects of chlorpromazine and filipin on the synthesis of corticosterone and stability of lysosomes and mitochondria in the rat adrenal;Haksar;BBA - General Sub.,1972

4. Lansoprazole exacerbates pemetrexed-mediated hematologic toxicity by competitive inhibition of renal basolateral human organic anion transporter 3;Ikemura;Drug Metab. Dispos.,2016

5. Drug repositioning of proton pump inhibitors for enhanced efficacy and safety of cancer chemotherapy;Ikemura;Front. Pharmacol.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding mechanisms of resistance to HER2-targeted therapies in HER2-positive breast cancer;Overcoming Cancers Resistant to HER-2 Antibodies;2024

2. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer;Cancer Treatment Reviews;2023-02

3. Do antibody–drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study;Frontiers in Pharmacology;2022-11-09